These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28035322)

  • 1. Micropapillary Bladder Cancer: Insights from the National Cancer Database.
    Sui W; Matulay JT; James MB; Onyeji IC; Theofanides MC; RoyChoudhury A; DeCastro GJ; Wenske S
    Bladder Cancer; 2016 Oct; 2(4):415-423. PubMed ID: 28035322
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncologic Outcomes of cT1 and cT2 Micropapillary Variant Compared with cT1 and cT2 Conventional Urothelial Carcinoma Treated with Radical Cystectomy.
    Ginsburg KB; Schober JP; Bukavina L; Murray N; Chandra AA; Chen DYT; Greenberg RE; Viterbo R; Uzzo RG; Smaldone MC; Kutikov A; Correa AF
    Urol Pract; 2022 Sep; 9(5):396-404. PubMed ID: 37145732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.
    Fernández MI; Williams SB; Willis DL; Slack RS; Dickstein RJ; Parikh S; Chiong E; Siefker-Radtke AO; Guo CC; Czerniak BA; McConkey DJ; Shah JB; Pisters LL; Grossman HB; Dinney CP; Kamat AM
    BJU Int; 2017 May; 119(5):684-691. PubMed ID: 27753185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micropapillary bladder cancer: current treatment patterns and review of the literature.
    Willis DL; Flaig TW; Hansel DE; Milowsky MI; Grubb RL; Al-Ahmadie HA; Plimack ER; Koppie TM; McConkey DJ; Dinney CP; Hoffman VA; Droller MJ; Messing E; Kamat AM
    Urol Oncol; 2014 Aug; 32(6):826-32. PubMed ID: 24931270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database.
    Vourganti S; Harbin A; Singer EA; Shuch B; Metwalli AR; Agarwal PK
    J Cancer; 2013; 4(4):336-42. PubMed ID: 23678370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micropapillary bladder cancer: a clinico-pathological characterization and treatment analysis.
    Li Z; Liao H; Tan Z; Mao D; Wu Y; Xiao YM; Yang SK; Zhong L
    Clin Transl Oncol; 2017 Oct; 19(10):1217-1224. PubMed ID: 28432572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Natural History, Treatment Pattern, and Outcomes of Patients With Micropapillary Bladder Carcinoma.
    Wang J; Wang FW
    Am J Clin Oncol; 2015 Oct; 38(5):472-8. PubMed ID: 24064750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.
    Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG
    Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micropapillary bladder cancer: an evolving biology.
    Lonati C; Simeone C; Suardi N; Briganti A; Montorsi F; Moschini M
    Curr Opin Urol; 2022 Sep; 32(5):504-510. PubMed ID: 35855578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
    Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB
    Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
    Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
    Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
    Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer.
    Koehne EL; Bakaloudi DR; Ghali F; Nyame Y; Schade GR; Grivas P; Yezefski TA; Hawley JE; Yu EY; Hsieh AC; Montgomery RB; Psutka SP; Gore JL; Wright JL
    Clin Genitourin Cancer; 2024 Jun; 22(3):102100. PubMed ID: 38763862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes.
    Abufaraj M; Foerster B; Schernhammer E; Moschini M; Kimura S; Hassler MR; Preston MA; Karakiewicz PI; Remzi M; Shariat SF
    Eur Urol; 2019 Apr; 75(4):649-658. PubMed ID: 30553613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer.
    Sui W; Matulay JT; Onyeji IC; Theofanides MC; James MB; RoyChoudhury A; Wenske S; DeCastro GJ
    World J Urol; 2017 Jul; 35(7):1055-1061. PubMed ID: 27803966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder.
    Ghoneim IA; Miocinovic R; Stephenson AJ; Garcia JA; Gong MC; Campbell SC; Hansel DE; Fergany AF
    Urology; 2011 Apr; 77(4):867-70. PubMed ID: 21296399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer.
    Meeks JJ; Taylor JM; Matsushita K; Herr HW; Donat SM; Bochner BH; Dalbagni G
    BJU Int; 2013 Jun; 111(8):E325-30. PubMed ID: 23384236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
    Mitra AP; Fairey AS; Skinner EC; Boorjian SA; Frank I; Schoenberg MP; Bivalacqua TJ; Hyndman ME; Reese AC; Steinberg GD; Large MC; Hulsbergen-van de Kaa CA; Bruins HM; Daneshmand S
    Urol Oncol; 2019 Jan; 37(1):48-56. PubMed ID: 30446450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging.
    Audenet F; Sfakianos JP; Waingankar N; Ruel NH; Galsky MD; Yuh BE; Gin GE
    Urol Oncol; 2019 Feb; 37(2):116-122. PubMed ID: 30509868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA.
    Hanna N; Trinh QD; Seisen T; Vetterlein MW; Sammon J; Preston MA; Lipsitz SR; Bellmunt J; Menon M; Choueiri TK; Abdollah F
    Eur Urol Oncol; 2018 May; 1(1):83-90. PubMed ID: 31100232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.